The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population

Trial Profile

The Strategy in the Prevention of Renal Post-transplant Cytomegalovirus Infection Among Chinese Population

Recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs Ganciclovir (Primary) ; Ganciclovir (Primary) ; Valganciclovir (Primary)
  • Indications Cytomegalovirus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top